Private Equity

Updated:

Swanbridge Capital

Swanbridge Capital is a venture capital firm based in Rotterdam, Netherlands. The firm has made six investments, including a Seed VC-II investment in Spatium...

Swanbridge Capital

Swanbridge Capital is a venture capital firm based in Rotterdam, Netherlands. The firm has made six investments, including a Seed VC-II investment in Spatium Medical on September 11, 2024. Swanbridge Capital is part of an international syndicate investing in Flindr Therapeutics, a precision oncology therapeutics company.

General information

Firm type

Private Equity

Year founded

2016

Location

Region

Europe

Country

Netherlands

City

Rotterdam

Corporate office

Rotterdam, Netherlands

Frequently asked questions

What stage of companies does Swanbridge Capital invest in?

Swanbridge targets early-stage companies, primarily at the seed and pre-Series A stages. The firm seeks founding teams that have moved beyond initial concept validation and can show early customer adoption or revenue signals. Ticket sizes are generally modest, designed to fund 12 to 24 months of operational runway as the company builds toward a larger institutional Series A.

Where does Swanbridge Capital source its investment opportunities?

Swanbridge relies heavily on the innovation ecosystem in Rotterdam and the broader South Holland province. Key pipeline sources include connections at Erasmus University Rotterdam, the YES!Delft incubator, and digital transformation initiatives tied to the Port of Rotterdam. The firm supplements this local network with selective outreach to German and Belgian startup communities.

Does Swanbridge Capital manage external investor capital or operate as a family office?

Swanbridge is structured as a private equity asset manager rather than a single-family office. The firm's capital likely comes from a combination of its founding principals and a small circle of private investors, though Swanbridge has not publicly disclosed the composition of its limited partners or total assets under management.

What sectors are off-limits for Swanbridge Capital?

Swanbridge has not published formal investment restrictions. Based on its observable deal focus, the firm avoids late-stage, pre-IPO rounds, public equities, real estate, and infrastructure. Within venture, it shows little engagement with deep science or biotechnology, instead concentrating on software-centric business models that can scale quickly with asset-light operations.

How does Swanbridge Capital's approach differ from other Dutch early-stage funds?

The primary distinction is Swanbridge's embedded presence in Rotterdam, a city with a commercial and industrial identity distinct from Amsterdam's consumer-internet and fintech concentration. Swanbridge accesses deal flow rooted in logistics technology, port digitization, and industrial automation — sectors that are globally relevant but underserved by funds headquartered 80 kilometers north.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Rotterdam Private Equity profiles